Trials / Terminated
TerminatedNCT01520740
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Aeris Therapeutics · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effects of baseline collateral ventilation status on outcomes following treatment with AeriSeal System in patients with advanced upper-lobe predominant heterogenous emphysema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Emphysematous Lung Sealant | 4 Subsegments treated - 2 each bilaterally |
| DEVICE | Emphysematous Lung Sealant | 4 Subsegments treated - 2 each bilaterally |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-01-30
- Last updated
- 2013-11-14
Locations
13 sites across 2 countries: Germany, Israel
Source: ClinicalTrials.gov record NCT01520740. Inclusion in this directory is not an endorsement.